Cornerstone Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CORNERSTONE
CORNERSTONE has two approved drugs.
Summary for Cornerstone
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
| Patent Litigation for Cornerstone: | See patent lawsuits for Cornerstone |
Drugs and US Patents for Cornerstone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cornerstone | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 076750-001 | Jun 28, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cornerstone | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 076743-001 | May 7, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

